Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the fourth quarter and year ended 31st March, 2026

SMSPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-5.3%1-day move

₹378.90

prior close

₹379.95

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.2-0.8-0.6-0.8-5.3-4.9-6.0-6.6-2.5+0.3+0.3+0.3——

Up moveDown movePending

AI summary

SMS Pharmaceuticals has informed exchanges that an audio recording of its analyst/investor conference call held on May 27, 2026 is now available on the company's website. The call discussed the audited financial results for Q4 and the year ended March 31, 2026. This is a disclosure filing under SEBI regulations to make the call recording publicly accessible. The actual content of the management commentary, numbers discussed, or guidance provided would be in the recording itself, which is not included in this regulatory filing.

Likely market impact

This filing indicates transparency and compliance but does not itself convey any material information. Investors wishing to understand Q4/FY26 performance or forward guidance would need to access the actual recording on the company's website.